Hiroaki Nagashima

1.9k total citations
93 papers, 1.4k citations indexed

About

Hiroaki Nagashima is a scholar working on Genetics, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hiroaki Nagashima has authored 93 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 20 papers in Molecular Biology and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hiroaki Nagashima's work include Glioma Diagnosis and Treatment (26 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Hiroaki Nagashima is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Hiroaki Nagashima collaborates with scholars based in Japan, United States and Belgium. Hiroaki Nagashima's co-authors include Takashi Sasayama, Kazuhiro Tanaka, Eiji Kohmura, Yoshio Nakamura, S. Mori, Daniel P. Cahill, Hiroaki Wakimoto, Yasuhiro Irino, Kohkichi Hosoda and Katsusuke Kyotani and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Scientific Reports.

In The Last Decade

Hiroaki Nagashima

88 papers receiving 1.3k citations

Peers

Hiroaki Nagashima

GENET

RNMI

ONCOL

Thomas Viel France

Herwig Strik Germany

Kensuke Tateishi Japan

Abhik Ray‐Chaudhury United States

Frank Duffner Germany

Cathérine Ghezzi France

Yuanqing Yan United States

Shin-Hyuk Kang South Korea

Stéphan Saïkali France

Chuanlu Jiang China

Thomas Viel France

Hiroaki Nagashima

397 ×0.7

172 ×0.5

GENET

190 ×0.6

236 ×1.2

RNMI

157 ×0.9

ONCOL

Citations per year, relative to Hiroaki Nagashima Hiroaki Nagashima (= 1×) peers Thomas Viel

Countries citing papers authored by Hiroaki Nagashima

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Nagashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Nagashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Nagashima more than expected).

Fields of papers citing papers by Hiroaki Nagashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Nagashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Nagashima. The network helps show where Hiroaki Nagashima may publish in the future.

Co-authorship network of co-authors of Hiroaki Nagashima

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Nagashima. A scholar is included among the top collaborators of Hiroaki Nagashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Nagashima. Hiroaki Nagashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Qu, Bo Luo, Xinchen Sun, et al.. (2025). Non-histone lysine lactylation: Emerging roles in tumor biology and therapeutic implications. Ageing Research Reviews. 112. 102875–102875. 1 indexed citations

Sasayama, Takashi, et al.. (2024). Potential of GSPT1 as a novel target for glioblastoma therapy. Cell Death and Disease. 15(8). 572–572. 3 indexed citations

Chang, Jenny Chia-Chen, Hiroaki Nagashima, Yosuke Kitagawa, et al.. (2024). CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition. Clinical Cancer Research. 30(14). 2996–3005. 8 indexed citations

Sasayama, Takashi, et al.. (2023). SURG-20. USEFULNESS OF PHOTODYNAMIC THERAPY (PDT) WITH TALAPORFIN SODIUM FOR GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v265–v266. 1 indexed citations

Nagashima, Hiroaki, Kazuhiro Tanaka, Shigeki Yamanishi, & Takashi Sasayama. (2023). P11.08.B R-MPV THERAPY FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; SINGLE CENTER RETROSPECTIVE ANALYSIS. Neuro-Oncology. 25(Supplement_2). ii73–ii73. 1 indexed citations

Tanaka, Kazuhiro, Hiroaki Nagashima, Hirotomo Tanaka, et al.. (2022). Glutamic Acid and Total Creatine as Predictive Markers for Epilepsy in Glioblastoma by Using Magnetic Resonance Spectroscopy Before Surgery. World Neurosurgery. 160. e501–e510. 4 indexed citations

Tanaka, Kazuhiro, Takashi Sasayama, Hiroaki Nagashima, et al.. (2021). Glioma cells require one-carbon metabolism to survive glutamine starvation. Acta Neuropathologica Communications. 9(1). 16–16. 35 indexed citations

Maeyama, M, Kazuhiro Tanaka, Masamitsu Nishihara, et al.. (2021). Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model. Scientific Reports. 11(1). 79–79. 27 indexed citations

Higuchi, Fumi, Hiroaki Nagashima, Jianfang Ning, et al.. (2020). Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair. Clinical Cancer Research. 26(7). 1690–1699. 88 indexed citations

10.

Nagashima, Hiroaki, Christine K. Lee, Kensuke Tateishi, et al.. (2020). Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells. Cancer Discovery. 10(11). 1672–1689. 43 indexed citations

11.

Li, Ming, Ameya R. Kirtane, Juri Kiyokawa, et al.. (2020). Local Targeting of NAD+ Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma. Cancer Research. 80(22). 5024–5034. 38 indexed citations

12.

Miller, Julie J., Alexandria L. Fink, Hiroaki Nagashima, et al.. (2020). Sirtuin activation targets IDH-mutant tumors. Neuro-Oncology. 23(1). 53–62. 19 indexed citations

13.

Kohta, Masaaki, Takashi Sasayama, Kazuhiro Tanaka, et al.. (2020). Intraoperative 3-T Magnetic Resonance Spectroscopy for Detection of Proliferative Remnants of Glioma. World Neurosurgery. 137. 149–157. 4 indexed citations

14.

Sasayama, Takashi, Kazuhiro Tanaka, Katsusuke Kyotani, et al.. (2019). DWI for Monitoring the Acute Response of Malignant Gliomas to Photodynamic Therapy. American Journal of Neuroradiology. 40(12). 2045–2051. 5 indexed citations

15.

Imahori, Taichiro, Kohkichi Hosoda, Yusuke Yamamoto, et al.. (2017). Combined metabolic and transcriptional profiling identifies pentose phosphate pathway activation by HSP27 phosphorylation during cerebral ischemia. Neuroscience. 349. 1–16. 19 indexed citations

16.

Nagashima, Hiroaki, Katsu Mizukawa, Masaaki Taniguchi, Yusuke Yamamoto, & Eiji Kohmura. (2017). Cerebrospinal fluid leakage and Chiari I malformation with Gorham's disease of the skull base: A case report. Neurologia i Neurochirurgia Polska. 51(5). 427–431. 7 indexed citations

17.

Nagashima, Hiroaki, K Hanada, & Isao Hashimoto. (1999). Correlation of skin phototype with facial wrinkle formation. Photodermatology Photoimmunology & Photomedicine. 15(1). 2–6. 29 indexed citations

18.

Ito, Hajime, Kenneth M. Yamada, Hiroaki Nagashima, et al.. (1994). Synthesis and Biological Activity of New 3-Hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) Synthase Inhibitors: 2-Oxetanones with a Side Chain Mimicking the Folded Structure of 1233A.. Chemical and Pharmaceutical Bulletin. 42(3). 512–520. 10 indexed citations

19.

Nagashima, Hiroaki, et al.. (1993). Incidence and prognosis of dysvascular amputations in Okayama Prefecture (Japan). Prosthetics and Orthotics International. 17(1). 9–13. 12 indexed citations

20.

Nakamura, Yoshio, Hiroaki Nagashima, & S. Mori. (1973). Bilateral effects of the afferent impulses from the masseteric muscle on the trigeminal motoneuron of the cat. Brain Research. 57(1). 15–27. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact